Show simple item record

dc.contributorUniversitat Ramon Llull. Facultat de Ciències de la Salut Blanquerna
dc.contributor.authorTorres-Novellas, Berta
dc.contributor.authorGuayta-Escolies, Rafel
dc.contributor.authorRius, Pilar
dc.contributor.authorCastellà, Amparo
dc.contributor.authorGascón Lecha, M. Pilar
dc.contributor.authorModamio, Pilar
dc.contributor.authorMariño, Eduardo L.
dc.date.accessioned2024-03-12T19:25:13Z
dc.date.available2024-03-12T19:25:13Z
dc.date.created2020-10
dc.date.issued2020-11
dc.identifier.urihttp://hdl.handle.net/20.500.14342/4009
dc.description.abstractThe prevalence of elderly patients with chronic illnesses, associated polypharmacy and a high risk of functional and cognitive impairment has increased in recent years. The care of Complex Chronic Patients (CCP) therefore represents a challenge for health systems in developed countries around the world. This paper presents a study protocol that will explore the effects of an intervention within a pharmaceutical care programme (PCAF) on optimising CCP care and on the suitability of the organisational methods proposed for the PCAF programme. This is a multicentre experimental study. The setting will be primary health care and community pharmacies in the so-called ‘autonomous community’ of Catalonia in Spain. The participants will be CPP attended to Primary Healthcare Centres with the CCP code in their electronic medical record. The included CCP will be distributed in two strata depending on whether they will be considered likely to receive the arranged medicinal treatment as Monitored Dosage System according to benefits based on criteria or not. They will then be assigned by random stratified sampling at a ratio of 1:1 to the control or intervention groups. A sample size of 860 patients is estimated. Patients will undergo 12 months follow-up. The primary outcome of this study will be the medication adherence measured by the Morisky Green Test and the billing/prescription ratio.ca
dc.format.extent5 p.ca
dc.language.isoengca
dc.publisherOATca
dc.relation.ispartofTrends in Medicine, 2020, 21: 1-5ca
dc.rights© L'autor/aca
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.otherMalalts crònicsca
dc.subject.otherMalalties cròniques -- Tractamentca
dc.subject.otherFarmàciaca
dc.subject.otherServeis d'atenció integradaca
dc.subject.otherProtocols clínicsca
dc.titleA study protocol for an experimental study for a pharmaceutical care programme to improve chronic complex disease management: PCAF programmeca
dc.typeinfo:eu-repo/semantics/articleca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc614ca
dc.subject.udc615ca
dc.identifier.doihttps://doi.org/10.15761/TiM.1000262ca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

© L'autor/a
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint